Это важно.

Мы предлагаем удобный сервис для тех, кто хочет купить – продать: земельный участок, дом, квартиру, коммерческую или элитную недвижимость в Крыму. //crimearealestat.ucoz.ru/ Перепечатка материалов разрешена только при условии прямой гиперссылки //allmedicine.ucoz.com/

Поиск

Реклама

Statistics


Онлайн всього: 1
Гостей: 1
Користувачів: 0

Нас смотрят

free counters

Ссылки.

Мы предлагаем удобный сервис для тех, кто хочет купить – продать: земельный участок, дом, квартиру, коммерческую или элитную недвижимость в Крыму. //crimearealestat.ucoz.ru/

Чат

Ecovigilance and Antibiotic Resistance: Relationship and Minimization of Risks

Ecovigilance plays a crucial role in addressing the environmental impact of pharmaceuticals, particularly in the growing problem of antibiotic resistance. Antibiotics, after being excreted by humans and animals or through improper disposal, can persist in the environment and contribute to the development of antimicrobial resistance (AMR). Ecovigilance, as a monitoring and management system, helps track and mitigate the ecological impact of antibiotic residues in the environment.


1. Relationship Between Ecovigilance and Antibiotic Resistance

A. How Antibiotics Enter the Environment

Antibiotics can enter the environment through several pathways:

  • Human Excretion: After use, unmetabolized antibiotics are excreted through urine and feces into wastewater.
  • Improper Disposal: Unused or expired antibiotics are sometimes disposed of improperly (e.g., flushing them down the toilet), leading to environmental contamination.
  • Agriculture and Veterinary Use: Antibiotics used in animal farming (e.g., livestock, poultry, and aquaculture) often leach into soil and water systems through manure or runoff from agricultural fields.

Once in the environment, these antibiotics can remain in soil, water bodies, and sediments for extended periods, leading to the selection of resistant bacteria. These bacteria can then transfer resistance genes to other bacteria, exacerbating the global AMR crisis.

B. Environmental Hotspots for Antibiotic Resistance Development

  • Wastewater Treatment Plants (WWTPs): Though these facilities are designed to treat sewage, they are often ineffective at completely removing antibiotic residues. WWTPs can act as reservoirs for antibiotic-resistant bacteria (ARB) and resistance genes, which are then released into natural water bodies.
  • Agricultural Fields: The application of manure or sludge containing antibiotic residues to agricultural land creates a breeding ground for resistant bacteria in the soil.

C. Consequences of Antibiotic Resistance in the Environment

  • Spread of Resistance Genes: Once resistant bacteria are present in the environment, they can transfer their resistance genes to other bacterial species through horizontal gene transfer.
  • Human Health Risk: Resistant bacteria can eventually reach humans through contaminated water, food, or direct contact, leading to infections that are difficult to treat.
  • Environmental Impact: Antibiotic resistance in the environment disrupts ecosystems, affecting microbial communities and the balance of natural microbial functions.

2. Minimization of Risks: Strategies for Ecovigilance and Antibiotic Resistance

To mitigate the environmental impact of antibiotic residues and reduce the risk of antimicrobial resistance, several strategies can be implemented:

A. Strengthening Ecovigilance Systems

Ecovigilance involves monitoring and managing the environmental impacts of pharmaceuticals, including antibiotics. Strengthening these systems can help identify antibiotic hotspots and develop targeted interventions.

  • Environmental Risk Assessments (ERAs): Pharmaceutical companies should be required to conduct comprehensive ERAs for antibiotics during drug development, assessing their persistence, bioaccumulation, and toxicity in the environment.
  • Monitoring and Reporting: Implement monitoring programs to regularly assess the presence of antibiotic residues and resistant bacteria in soil, water bodies, and agricultural runoff. Data from this monitoring can inform public health interventions and policy decisions.

B. Improved Wastewater Treatment Technologies

Current wastewater treatment plants (WWTPs) are not fully effective at removing antibiotics from sewage, and therefore, enhanced treatment technologies are necessary.

  • Advanced Oxidation Processes (AOPs): These processes can break down antibiotic residues more effectively, preventing them from being released into water bodies.
  • Membrane Filtration: Technologies like ultrafiltration and reverse osmosis can remove antibiotics and resistant bacteria from wastewater.
  • Constructed Wetlands: These natural systems can be used to remove contaminants, including antibiotics, from wastewater through plant-microbe interactions.

C. Regulation of Antibiotic Use in Agriculture

The widespread use of antibiotics in animal farming is a major contributor to environmental antibiotic residues and AMR. Regulatory actions should focus on:

  • Reducing Antibiotic Use: Implementing strict regulations to limit the use of antibiotics in agriculture, particularly the use of medically important antibiotics for growth promotion in livestock.
  • Alternatives to Antibiotics: Encouraging the use of probiotics, prebiotics, and vaccines as alternatives to antibiotics in animal husbandry.
  • Monitoring Agricultural Practices: Regularly monitoring the use of antibiotics in farming and ensuring that manure or sludge containing antibiotic residues is properly treated before being applied to fields.

D. Public Awareness and Proper Drug Disposal

Improper disposal of unused antibiotics contributes to environmental contamination, leading to antibiotic resistance. Public awareness campaigns and regulatory measures can reduce improper disposal.

  • Take-back Programs: Establishing pharmaceutical take-back programs where patients can return unused antibiotics for proper disposal.
  • Education Campaigns: Public health campaigns should focus on educating people about the dangers of improper disposal of antibiotics and promoting safe disposal practices.
  • Pharmacy Involvement: Pharmacists can play a critical role in educating patients on proper disposal and the risks associated with misuse of antibiotics.

E. Promoting Sustainable Antibiotic Development

Pharmaceutical companies can develop more environmentally friendly antibiotics by designing drugs that are:

  • Less persistent: Developing antibiotics that degrade more quickly in the environment.
  • Targeted and Narrow-spectrum: Encouraging the development of antibiotics that target specific pathogens, reducing the impact on the broader microbial ecosystem.
  • Reduced Dosage Regimens: Promoting antibiotics that require shorter treatment durations, thereby reducing the amount of drug that ends up in the environment.

F. International Collaboration

Given the global nature of antibiotic resistance, international cooperation is essential to tackle AMR in the environment.

  • Global Surveillance Networks: Participation in global networks that monitor antibiotic resistance, such as the World Health Organization's Global Antimicrobial Resistance Surveillance System (GLASS), can help track the spread of resistance in the environment.
  • Harmonized Regulations: Collaborating across countries to create consistent regulations regarding antibiotic use in humans, animals, and agriculture to minimize environmental contamination.

3. Case Study: Antibiotic Resistance in Wastewater

Background

A study conducted in Europe found high levels of antibiotic residues and resistant bacteria in wastewater effluents from hospitals and urban areas. These effluents were released into rivers that supplied drinking water to downstream populations.

Findings:

  • High concentrations of antibiotics, such as ciprofloxacin and sulfamethoxazole, were detected in treated wastewater.
  • Significant levels of antibiotic-resistant bacteria and resistance genes were found in the river water, particularly near wastewater discharge points.
  • The presence of these resistant bacteria posed a potential risk for both environmental health and human exposure.

Intervention:

  • The local government implemented advanced wastewater treatment technologies, including membrane filtration and ultraviolet (UV) disinfection, to reduce antibiotic residues and resistant bacteria in effluents.
  • Regular environmental monitoring was initiated to assess the effectiveness of the interventions.
  • Educational programs on proper drug disposal were launched to reduce the improper disposal of antibiotics by the public.

Outcome:

  • After the intervention, levels of antibiotic residues and resistant bacteria in the wastewater effluents were significantly reduced.
  • Continued environmental monitoring ensured early detection of any re-emergence of resistance.

4. Conclusion

Ecovigilance is essential in managing the environmental impacts of antibiotics, particularly in the fight against antibiotic resistance. By enhancing monitoring systems, improving wastewater treatment, regulating agricultural antibiotic use, and raising public awareness, we can reduce the ecological impact of antibiotics and minimize the development of antimicrobial resistance. Effective collaboration between healthcare systems, pharmaceutical companies, environmental scientists, and policymakers is crucial to safeguarding both human and environmental health from the risks of antibiotic resistance.

Раскрутка сайта - регистрация в каталогах PageRank Checking Icon Яндекс цитирования